Ali Rizvi to Clinical Trials as Topic
This is a "connection" page, showing publications Ali Rizvi has written about Clinical Trials as Topic.
Connection Strength
0.016
-
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opin Investig Drugs. 2009 Oct; 18(10):1495-503.
Score: 0.016